ARA-290 is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
The most common research dosage for ARA-290 is 2-4 mg daily, administered once daily via subcutaneous injection. Typical cycles run 28 days typical; 8-16 weeks for extended response. With a half-life of approximately 24 hours, timing matters for optimal results.
What Is ARA-290 and Why Does Dosing Matter?
ARA-290 (Erythropoietin-derived tissue-protective peptide) is a Innate repair receptor agonist, anti-inflammatory peptide. Synthetic 11-amino acid peptide engineered from the tissue-protective domain of erythropoietin (EPO). Getting the dosage right is critical — too little may produce no measurable effect, while excessive amounts increase risk without proportional benefit.
The standard research dosage for ARA-290 has been established through preclinical studies and community protocols. This guide covers the evidence-backed dosing range, timing, and cycle structure.
What Is the Recommended ARA-290 Dosage?
The most widely used ARA-290 dosage is 2-4 mg daily, administered once daily via subcutaneous injection.
Beginners should start at the lower end of this range and titrate upward only if needed. The half-life of ARA-290 is approximately 24 hours, which directly determines how often you need to dose to maintain stable blood levels.
For ARA-290 specifically, the 28 days typical; 8-16 weeks for extended response cycle length is standard. Longer isn't always better — Innate repair receptor agonist, anti-inflammatory peptide compounds require cycling to maintain receptor sensitivity.
When Should You Dose ARA-290?
With a half-life of approximately 24 hours, timing your ARA-290 administration affects peak blood levels. Most protocols call for once daily.
For peptides administered before bed (common with GH-related compounds), the goal is to amplify the natural nocturnal growth hormone pulse. For healing peptides, proximity to the injury site via local injection can improve outcomes.
Calculate Your ARA-290 Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for ARA-290.
Open Calculator →How Do You Reconstitute ARA-290?
ARA-290 typically comes as a lyophilized (freeze-dried) powder. Reconstitute with bacteriostatic water — never saline or sterile water, as BAC water contains 0.9% benzyl alcohol that prevents bacterial growth and extends shelf life to 4-6 weeks.
Use our peptide dosing calculator to determine the exact amount of BAC water to add based on your vial size and desired dose per injection.
How Long Should a ARA-290 Cycle Last?
Standard ARA-290 cycles run 28 days typical; 8-16 weeks for extended response. This timeframe is based on the compound's mechanism and the time needed to observe measurable effects.
Clinical trials in sarcoidosis-associated small fiber neuropathy and type 2 diabetes showed significant pain reduction and nerve regeneration. A 28-day protocol initiated measurable corneal nerve fiber regrowth. Chronic stress studies showed antidepressant effects comparable to fluoxetine. 4+ completed clinical trials in humans.
What Side Effects Can Affect Dosing?
Safe profile in multiple clinical trials. Minimal reported adverse events. Occasional mild injection site reactions. No serious safety concerns identified across diabetes, sarcoidosis, and neuropathy patient populations.
If side effects emerge, the first step is typically reducing the dose rather than discontinuing entirely. Most ARA-290-related side effects are dose-dependent.
How Does ARA-290 Dosing Change When Stacking?
Synergizes with BPC-157 for comprehensive tissue repair — ARA-290 handles neuropathic and inflammatory pathways while BPC-157 targets connective tissue and gut healing.
When stacking, some researchers reduce individual peptide doses by 20-30% since synergistic effects mean full doses of each aren't always necessary.
What Is the Bottom Line on ARA-290 Dosing?
Start at 2, dose once daily, and run cycles of 28 days typical; 8-16 weeks for extended response. Monitor your response and adjust within the established range.
Source matters — always use research-grade ARA-290 from vendors with third-party COA testing. Underdosed or contaminated products are the most common reason for poor results.
Related Reading
- ARA-290 Benefits
- ARA-290 Side Effects
- ARA-290 Stacking Guide
- ARA-290 Cycle Guide
- ARA-290 Research
- BPC-157 Complete Guide
Research-Grade Sourcing
If you're going to research ARA-290, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is ARA-290?
ARA-290 (Erythropoietin-derived tissue-protective peptide) is a Innate repair receptor agonist, anti-inflammatory peptide. Synthetic 11-amino acid peptide engineered from the tissue-protective domain of erythropoietin (EPO). It is researched for neuropathic pain relief, inflammation reduction, nerve fiber regeneration, improved autonomic function, metabolic control in diabetes.
What is the recommended ARA-290 dosage?
Common dosages: 2-4 mg daily administered once daily via subcutaneous injection. Cycle length: 28 days typical; 8-16 weeks for extended response. Half-life: approximately 24 hours. Use our peptide calculator for exact reconstitution math.
What are the side effects of ARA-290?
Safe profile in multiple clinical trials. Minimal reported adverse events. Occasional mild injection site reactions. No serious safety concerns identified across diabetes, sarcoidosis, and neuropathy patient populations.
Is ARA-290 safe?
ARA-290 has shown a preliminary safety profile in research. Investigational. Underwent Phase II clinical trials. Not FDA-approved. All research should follow appropriate safety protocols.